Fig. 1
From: Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
SPECT/CT imaging with two projections per mouse, frontal and sagittal view, arrows indicating xenografts. a From left to right, a mouse with LNCaP xenograft (right side) imaged at 24, 48, 72, and 1 week p.i. of 8 MBq 177Lu-m11B6. b Mouse with LNCaP xenograft (right side) imaged at 48 and 72 h p.i. of 8 MBq 177Lu-m11B6 and m11B6. 1 mg cold m11B6 was injected 24 h prior to injection with 177Lu-m11B6